The expertise and commitment of our R&D and management teams and the fruitful collaboration with independent or academic research institutes and recognized contract research organizations has brought Neurim Pharmaceuticals remarkable successes in drug discovery and development. Neurim Pharmaceuticals has one product registrated and approved for marketing, several Phase II/III projects to develop new indications and further 19 internally developed NCEs at various stages of preclinical and clinical development. All products of Neurim Pharmaceuticals are based on small molecule chemical synthesis.